Thrivent Financial for Lutherans’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.8M | Sell |
635,265
-174,928
| -22% | -$4.66M | 0.03% | 458 |
|
|
2025
Q4 | $20.2M | Buy |
810,193
+72,504
| +10% | +$1.83M | 0.04% | 455 |
|
|
2025
Q3 | $18.8M | Buy |
737,689
+132,453
| +22% | +$3.27M | 0.04% | 409 |
|
|
2025
Q2 | $14.7M | Buy |
605,236
+83,335
| +16% | +$1.94M | 0.03% | 436 |
|
|
2025
Q1 | $13.3M | Sell |
521,901
-95,401
| -15% | -$2.5M | 0.03% | 499 |
|
|
2024
Q4 | $16.4M | Sell |
617,302
-229,280
| -27% | -$6.22M | 0.03% | 501 |
|
|
2024
Q3 | $24.5M | Buy |
846,582
+107,346
| +15% | +$3.13M | 0.05% | 413 |
|
|
2024
Q2 | $20.7M | Buy |
739,236
+20,140
| +3% | +$554K | 0.04% | 440 |
|
|
2024
Q1 | $20M | Sell |
719,096
-1,728,608
| -71% | -$48M | 0.04% | 464 |
|
|
2023
Q4 | $70.5M | Sell |
2,447,704
-571,494
| -19% | -$17.3M | 0.15% | 191 |
|
|
2023
Q3 | $100M | Buy |
3,019,198
+147,977
| +5% | +$5.23M | 0.24% | 110 |
|
|
2023
Q2 | $105M | Buy |
2,871,221
+128,204
| +5% | +$4.99M | 0.24% | 109 |
|
|
2023
Q1 | $112M | Sell |
2,743,017
-1,277,046
| -32% | -$55.2M | 0.27% | 89 |
|
|
2022
Q4 | $206M | Buy |
4,020,063
+2,153,070
| +115% | +$103M | 0.53% | 22 |
|
|
2022
Q3 | $81.7M | Buy |
1,866,993
+1,421,952
| +320% | +$69.1M | 0.22% | 113 |
|
|
2022
Q2 | $23.3M | Sell |
445,041
-121,469
| -21% | -$6.19M | 0.06% | 363 |
|
|
2022
Q1 | $29.8M | Buy |
566,510
+125,526
| +28% | +$6.51M | 0.06% | 345 |
|
|
2021
Q4 | $22M | Sell |
440,984
-999
| -0.2% | -$49.5K | 0.04% | 446 |
|
|
2021
Q3 | $18.8M | Sell |
441,983
-71,179
| -14% | -$3.15M | 0.04% | 480 |
|
|
2021
Q2 | $20.1M | Buy |
513,162
+1,698
| +0.3% | +$66K | 0.04% | 456 |
|
|
2021
Q1 | $18.5M | Sell |
511,464
-33,746
| -6% | -$1.2M | 0.04% | 466 |
|
|
2020
Q4 | $20.1M | Sell |
545,210
-35,065
| -6% | -$1.29M | 0.05% | 447 |
|
|
2020
Q3 | $20.2M | Sell |
580,275
-149,748
| -21% | -$5.25M | 0.05% | 395 |
|
|
2020
Q2 | $22.5M | Sell |
730,023
-1,355,001
| -65% | -$46M | 0.07% | 335 |
|
|
2020
Q1 | $64.5M | Sell |
2,085,024
-214,885
| -9% | -$7.32M | 0.23% | 103 |
|
|
2019
Q4 | $85.5M | Buy |
2,299,909
+83,530
| +4% | +$2.98M | 0.24% | 102 |
|
|
2019
Q3 | $75.6M | Sell |
2,216,379
-1,316,550
| -37% | -$47.9M | 0.23% | 114 |
|
|
2019
Q2 | $145M | Buy |
3,532,929
+170,088
| +5% | +$6.75M | 0.44% | 42 |
|
|
2019
Q1 | $136M | Sell |
3,362,841
-662,455
| -16% | -$26.5M | 0.43% | 48 |
|
|
2018
Q4 | $167M | Sell |
4,025,296
-99,930
| -2% | -$4.15M | 0.6% | 31 |
|
|
2018
Q3 | $172M | Sell |
4,125,226
-6,529
| -0.2% | -$251K | 0.54% | 34 |
|
|
2018
Q2 | $142M | Sell |
4,131,755
-288,033
| -7% | -$9.84M | 0.46% | 43 |
|
|
2018
Q1 | $149M | Buy |
4,419,788
+115,285
| +3% | +$3.96M | 0.5% | 44 |
|
|
2017
Q4 | $148M | Buy |
4,304,503
+44,242
| +1% | +$1.51M | 0.5% | 44 |
|
|
2017
Q3 | $144M | Sell |
4,260,261
-242,559
| -5% | -$7.8M | 0.51% | 43 |
|
|
2017
Q2 | $143M | Buy |
4,502,820
+59,924
| +1% | +$1.89M | 0.6% | 33 |
|
|
2017
Q1 | $144M | Sell |
4,442,896
-400,404
| -8% | -$12.6M | 0.62% | 31 |
|
|
2016
Q4 | $149M | Buy |
4,843,300
+155,302
| +3% | +$4.74M | 0.67% | 28 |
|
|
2016
Q3 | $151M | Sell |
4,687,998
-113,172
| -2% | -$3.78M | 0.69% | 23 |
|
|
2016
Q2 | $160M | Sell |
4,801,170
-36,385
| -0.8% | -$1.16M | 0.76% | 23 |
|
|
2016
Q1 | $136M | Buy |
4,837,555
+161,378
| +3% | +$4.61M | 0.66% | 30 |
|
|
2015
Q4 | $143M | Buy |
4,676,177
+285,519
| +7% | +$8.98M | 0.69% | 34 |
|
|
2015
Q3 | $131M | Buy |
4,390,658
+88,532
| +2% | +$2.84M | 0.69% | 32 |
|
|
2015
Q2 | $137M | Sell |
4,302,126
-303,026
| -7% | -$9.88M | 0.76% | 26 |
|
|
2015
Q1 | $152M | Buy |
4,605,152
+814,163
| +21% | +$25.9M | 0.84% | 22 |
|
|
2014
Q4 | $112M | Buy |
3,790,989
+322,840
| +9% | +$9.26M | 0.62% | 35 |
|
|
2014
Q3 | $97.3M | Sell |
3,468,149
-397,877
| -10% | -$11.2M | 0.56% | 41 |
|
|
2014
Q2 | $109M | Buy |
3,866,026
+296,701
| +8% | +$8.46M | 0.61% | 35 |
|
|
2014
Q1 | $109M | Buy |
3,569,325
+3,031,515
| +564% | +$90.4M | 0.67% | 34 |
|
|
2013
Q4 | $15.6M | Sell |
537,810
-98,233
| -15% | -$2.86M | 0.1% | 234 |
|
|
2013
Q3 | $17.3M | Sell |
636,043
-171,145
| -21% | -$4.66M | 0.11% | 209 |
|
|
2013
Q2 | $21.4K | Buy |
+807,188
| New | +$22.3M | 0.14% | 168 |
|
Other funds holding PFE
VCM
VPM
Thrivent Financial for Lutherans's PFE Position: Q1 2026 in Review
Thrivent Financial for Lutherans reduced its Pfizer (PFE) stake by 22% in Q1 2026, selling an estimated $4.66M and leaving 635,265 shares worth $17.8M. The position accounts for 0.03% of the portfolio, ranked #458.
Thrivent Financial for Lutherans first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $206M in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Thrivent Financial for Lutherans held 635,265 shares of Pfizer worth $17.8M as of Q1 2026.
- Thrivent Financial for Lutherans sold 174,928 Pfizer shares in Q1 2026, an estimated $4.66M.
- Pfizer made up 0.03% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #458 holding.
- Thrivent Financial for Lutherans first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Thrivent Financial for Lutherans's Pfizer position peaked at $206M in Q4 2022.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.